G. R. Burmester

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Daniel E. Fürst, Edward Keystone, Jürgen Braun et al. · Annals of the Rheumatic Diseases · 2011 · 692 citations

Medicine, Internal Medicine, Pharmacotherapy +16

Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibody

Gerd Horneff, G. R. Burmester, Frank Emmrich et al. · Arthritis & Rheumatism · 1991 · 278 citations

Life Sciences, Clinical Sciences, Immunology +17

Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice

Stefano Bombardieri, A. A. Ruiz, Patrice Fardellone et al. · Lara D. Veeken · 2007 · 178 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis

Stefan Bl��, Ann Union, Jos Raymackers et al. · Arthritis & Rheumatism · 2001 · 176 citations

Life Sciences, Immunology, Molecular Biology +17

Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.

Gernot Keyszer, Irini Lambiri, Rollin Nagel et al. · PubMed · 1999 · 160 citations

Medicine, Clinical Sciences, Internal Medicine +14